GlycoMimetics, Inc.
GLYC
$0.2495
-$0.0252-9.17%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -86.67% | -86.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -86.67% | -86.67% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -86.67% | -86.67% |
| SG&A Expenses | -5.02% | -10.97% | -5.07% | -3.95% | 0.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.25% | -8.71% | 4.14% | -9.83% | -17.26% |
| Operating Income | 17.23% | 8.74% | -4.12% | 9.69% | 17.15% |
| Income Before Tax | -2.66% | -4.39% | -4.62% | 12.07% | 20.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.66% | -4.39% | -4.62% | 12.07% | 20.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.66% | -4.39% | -4.62% | 12.07% | 20.97% |
| EBIT | 17.23% | 8.74% | -4.12% | 9.69% | 17.15% |
| EBITDA | 16.99% | 8.48% | -4.36% | 9.58% | 17.11% |
| EPS Basic | -0.58% | 3.14% | 7.47% | 25.84% | 34.30% |
| Normalized Basic EPS | 16.19% | 13.62% | 7.49% | 25.84% | 34.30% |
| EPS Diluted | -0.58% | 3.14% | 7.47% | 25.84% | 34.30% |
| Normalized Diluted EPS | 16.19% | 13.62% | 7.49% | 25.84% | 34.30% |
| Average Basic Shares Outstanding | 1.79% | 6.56% | 12.03% | 18.03% | 20.58% |
| Average Diluted Shares Outstanding | 1.79% | 6.56% | 12.03% | 18.03% | 20.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |